课题基金 / 基金详情

Melanoma Prevention: Using the Sun

Melanoma Prevention: Using the Sun
预防黑色素瘤:利用阳光
批准号:
8484362
负责人:
MARIANNE BERWICK
金额:
$15.97万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-07-05 至 2016-06-30
关键词:
AffectArsenicAustraliaAwardBasic ScienceBedsBehaviorBehavior TherapyBehavioralBiologicalCDKN2A geneCanadaCase-Control StudiesCessation of lifeCharacteristicsClinical ResearchCollaborationsConnecticutCounselingCutaneous MelanomaDNA Repair GeneDataData SetDevelopmentDiseaseEnrollmentEnvironmentEpidemiologyEpigenetic ProcessEtiologyEvaluationExtramural ActivitiesFacultyFamily history ofFemaleFosteringFundingGenderGenerationsGenesGeneticGenetic VariationGoalsGrantGrowthHandHereditary MelanomaHispanicsHormonalImmunologic FactorsImmunologyIncidenceIndividualInternationalInterventionInterviewInvestigationItalyK-Series Research Career ProgramsKnowledgeLaboratoriesLeadLeadershipLeftLesionMalignant NeoplasmsMedical StudentsMelissaMentorsMinorityModelingMolecular EpidemiologyMorbidity - disease rateNative AmericansNatureNevusNew MexicoNot Hispanic or LatinoNucleotide Excision RepairOccupationsPaperParental ConsentPathway interactionsPatientsPatternPhenotypePigmentation physiologic functionPlayPopulationPopulation ResearchPopulation SciencesPositioning AttributePostdoctoral FellowPredispositionPreventionRecording of previous eventsRecurrenceResearchResearch PersonnelResearch Project GrantsResearch ProposalsResearch SupportResistanceResourcesRiskRoleSamplingScientistSenior Scientist AwardSkinSkin CancerSkin tanningSolar elastosisSun ExposureSunburnSunlightTestingThe SunThinkingTimeTrainingTraining and InfrastructureTreatment FactorUV Radiation ExposureUnited StatesUniversitiesVariantVitamin DVitamin D3 ReceptorWorkbasecancer health disparitycancer preventioncancer riskcareereffective therapyevidence based guidelinesexperiencefollow-upgene environment interactionhigh riskimprovedmelanomamortalitynovelpopulation basedpre-doctoralprogramsskillstumor

项目摘要

项目成果

MARIANNE BERWICK的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): This application - Melanoma Prevention: Using the Sun - is intended to forward and develop Dr. Berwick's career goals. These are three-fold. (1) Ongoing goal: To conduct studies that will lead to understanding and eliminating morbidity and mortality from melanoma. After obtaining training in immunology, exposure assessment, and epidemiology at Yale University, Dr. Berwick began a systematic research agenda concentrating on the spectrum of cancer prevention for an eminently preventable disease - melanoma. Current studies focus on gene-environment interaction and factors important for survival with melanoma. (2) As a Result of K05 Support: To develop young pre-doctoral, post-doctoral and faculty into productive scientists. Dr. Berwick's research projects provide an excellent platform for new research by junior investigators. Examples of novel initiatives include exploration of interaction effects of sunlight and Vitamin D with the vitamin D receptor and its pathway, immunological factors and hormonal influences on both etiology and survival with melanoma. Her long history of successful mentoring clearly demonstrates Dr. Berwick's leadership skills in fostering the academic development of a new generation of cancer prevention scientists trained to investigate genetics and exposure in relationship to cancer risk. This award would provide time to support the expansion of this mentoring role by freeing up a portion of Dr. Berwick's administrative responsibilities. Dr. Berwick is ideally positioned to assume a senior mentoring role at this time since at the time of this award, all but her primary research supporting this proposal will have been completed or handed over to junior investigators, leaving 40% new time and effort available for new research and mentoring. (3) As a Result of K05 Support: Contribution to the continued growth and refinement of Dr. Berwick's Research Skills and Directions: To impact cancer health disparities in New Mexico by understanding their etiology and developing appropriate and regional-specific interventions. New initiatives to develop population-based case-control studies in New Mexico will provide important understandings of the novel disparities and patterns of cancer incidence, survival and mortality that are present among the state's major ethnic populations: Hispanics, non-Hispanic whites and Native Americans. Dr. Berwick's wide experience in population-based investigations and molecular epidemiology will facilitate these new studies. These goals will be realized through a strong mentoring program developed by Dr. Marianne Berwick, by improving the mentoring and training infrastructure through leveraging existing doctoral and post-doctoral programs and developing new doctoral and post-doctoral positions, and by more thoroughly examining extant and new data in melanoma etiology, progression and etiology which are collected through extramural funding. These goals have been developed through Dr. Berwick's 24 years of mentoring young faculty and investigating the role of solar exposure in the development and progression of cutaneous malignant melanoma. Dr. Berwick's goals - to understand and eliminate morbidity and mortality from melanoma - reflect national cancer priorities to eliminate suffering and death from cancer by 2015. NCI "will conduct and support basic, clinical and population research to gain a more complete understanding of the genetic, epigenetic, environmental, behavioral and socio-cultural determinants of cancer and the biological mechanisms underlying cancer resistance, susceptibility, initiation, regression, progression and recurrence. The NCI clearly states that prevention must be based on knowledge developed by integrative population science teams working in the population and in the laboratory.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Integration of Clinical and Molecular Biomarkers for Melanoma Survival
Integration of Clinical and Molecular Biomarkers for Melanoma Survival
CORE 1: Administrative
Integration of Clinical and Molecular Biomarkers for Melanoma Survival
海外基金